What is the global meningococcal vaccines market size in 2026?

The global meningococcal vaccines market is estimated to be valued at US$4.6 billion in 2026.

What is driving the meningococcal vaccines market?

Growing adoption of meningococcal conjugate vaccines, increasing demand for serogroup B protection, expansion of adolescent and pediatric immunization programs, broader combination vaccine adoption, and stronger outbreak preparedness are driving the growth of the meningococcal vaccines market.

What is the projected growth rate of the meningococcal vaccines market?

The meningococcal vaccines market is projected to grow at a CAGR of 6.2% between 2026 and 2033.

What are the key growth opportunities?

Increasing adoption of MenABCWY combination vaccines, expansion of infant vaccination programs, rising MenB vaccination among adolescents and young adults, and growing immunization programs across emerging economies are expected to create significant growth opportunities for market participants.

Who are the leading companies in the meningococcal vaccines market?

Key companies operating in the meningococcal vaccines market include GSK plc, Pfizer Inc., Sanofi, Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co., Ltd., Bharat Biotech International Ltd., Biological E. Limited, Incepta Pharmaceuticals Ltd., and Bio-Manguinhos/Fiocruz.

Table of Content - Meningococcal Vaccines Market Size, Share, Growth and Forecast, 2026

Executive Summary
1. Global Meningococcal Vaccines Market Snapshot, 2026and 2033
2. Market Opportunity Assessment, 2026– 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Specialty Clinics Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors – Relevance and Impact
Value Added Insights
1. Treatment Type Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Global Meningococcal Vaccines Market Outlook:
1. Key Highlights
  1. Market Size (US$ Bn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, 2025–2033
3. Global Meningococcal Vaccines Market Outlook: By Product
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Product,2020-2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026– 2033
    1. Meningococcal Polysaccharide Vaccine
    2. Meningococcal Conjugate Vaccine
    3. Serogroup B Meningococcal Vaccine
  4. Market Attractiveness Analysis: By Product
4. Global Meningococcal Vaccines Market Outlook: By Age Group
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Age Group,2020-2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2026– 2033
    1. Infants (0–24 months)
    2. Children (2–12 years)
    3. Adolescents and young adults
    4. Adults
  4. Market Attractiveness Analysis: Indication
5. Global Meningococcal Vaccines Market Outlook: By Distribution Channel
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel,2020-2025
  3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026– 2033
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
    4. Market Attractiveness Analysis: By Distribution Channel
Global Meningococcal Vaccines Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Region,2020-2025
3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026– 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product
  3. By Age Group
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. U.S.
  2. Canada
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026– 2033
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2026– 2033
  1. Infants (0–24 months)
  2. Children (2–12 years)
  3. Adolescents and young adults
  4. Adults
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026– 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Europe Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product
  3. By Age Group
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026– 2033
  1. Briefs
  2. Boxers
  3. Panties and Thongs
5. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2026– 2033
  1. Infants (0–24 months)
  2. Children (2–12 years)
  3. Adolescents and young adults
  4. Adults
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026– 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
East Asia Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product
  3. By Age Group
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026– 2033
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2026– 2033
  1. Infants (0–24 months)
  2. Children (2–12 years)
  3. Adolescents and young adults
  4. Adults
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026– 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
South Asia & Oceania Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product
  3. By Age Group
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026– 2033
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2026– 2033
  1. Infants (0–24 months)
  2. Children (2–12 years)
  3. Adolescents and young adults
  4. Adults
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026– 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Latin America Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product
  3. By Age Group
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026– 2033
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2026– 2033
  1. Infants (0–24 months)
  2. Children (2–12 years)
  3. Adolescents and young adults
  4. Adults
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026– 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Middle East & Africa Meningococcal Vaccines Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market,2020-2025
  1. By Country
  2. By Product
  3. By Age Group
3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026– 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2026– 2033
  1. Meningococcal Polysaccharide Vaccine
  2. Meningococcal Conjugate Vaccine
  3. Serogroup B Meningococcal Vaccine
5. Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2026– 2033
  1. Infants (0–24 months)
  2. Children (2–12 years)
  3. Adolescents and young adults
  4. Adults
6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026– 2033
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping by Market
  2. Competition Dashboard
3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
  1. GSK plc.
    1. Overview
    2. Segments and Treatment Types
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Pfizer Inc.
  3. Sanofi
  4. Merck & Co., Inc.
  5. Serum Institute of India Pvt. Ltd.
  6. Walvax Biotechnology Co., Ltd.
  7. Bharat Biotech International Ltd.
  8. Biological E. Limited
  9. Incepta Pharmaceuticals Ltd.
  10. Bio-Manguinhos/Fiocruz
  11. Minhai Biotechnology Co., Ltd.
  12. Hualan Biological Engineering Inc.
  13. Shenzhen Kangtai Biological Products Co., Ltd.
  14. Chongqing Zhifei Biological Products Co., Ltd.
  15. Panacea Biotec Ltd.
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Meningococcal Vaccines Market Size, Share, Growth and Forecast, 2026–2033

Quick Links

Our Partners

Secure Payments Through